Dashboard
Manage Tickers

OCGN


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ocugen-announced-that-dosing-is-complete-in-the-third-cohort-of-its-phase-12-gardian-clinical-trial-for-ocu410st-aav-hroraa-modifier-gene-therapy-candidate-being-developed-for-stargardt-disease
Ocugen Announced That Dosing Is Complete I...
08/28/2024 10:32:55

ocugen-receives-green-light-from-health-canada-for-phase-3-trial-of-gene-therapy-for-retinitis-pigmentosa
Ocugen Receives Green Light from Health Ca...
08/26/2024 11:09:30

Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ:OCGN), a biotechnology company focused on discovering, develop...

peering-into-ocugens-recent-short-interest
Peering Into Ocugen's Recent Short Interest
08/09/2024 20:15:16

ocugens-cash-cash-equivalents-and-restricted-cash-totaled-16m-as-of-june-30-2024-subsequent-to-june-30-2024-the-company-closed-a-public-offering-with-net-proceeds-of-326-millionextending-its-expected-cash-runway-into-the-third-quarter-of-2025
Ocugen's Cash, Cash Equivalents, And Restr...
08/08/2024 10:54:03

ocugen-q2-2024-gaap-eps-004-beats-006-estimate-sales-1141m
Ocugen Q2 2024 GAAP EPS $(0.04) Beats $(0....
08/08/2024 10:52:25

ocugen-announces-notification-from-fda-to-begin-its-expanded-access-program-for-treatment-of-adult-patients-with-ocu400
Ocugen Announces Notification From FDA To ...
08/05/2024 10:31:56

why-ocugen-ocgn-stock-is-falling
Why Ocugen (OCGN) Stock Is Falling
08/01/2024 13:18:41

Ocugen shares are trading lower by 11% Thursday morning. The company announced the pricing of its public offering.

reported-earlier-ocugen-prices-35m-public-offering-of-30434783-common-shares-at-115share
Reported Earlier, Ocugen Prices $35M Publi...
08/01/2024 06:55:13

ocugen-announces-underwritten-public-offering-of-common-stock-size-not-disclosed
Ocugen Announces Underwritten Public Offer...
07/31/2024 21:08:05

Grants Underwriter 30-Day Option To Purchase Additional 15% Shares; Offering Subject To Market And Other Conditions

ocugen-has-completed-dosing-in-third-cohort-of-phase-12-armada-trial-for-ocu410-aav-hrora-for-geographic-atrophy-the-company-has-initiated-phase-2-trial-to-assess-ocu410-in-larger-group-of-patients
Ocugen Has Completed Dosing In Third Cohor...
07/25/2024 10:41:52

ocugen-discloses-data-and-safety-monitoring-board-approves-enrollment-in-high-dose-cohort-3-in-gardian-study-for-stargardt-disease-company-says-it-established-medium-dose-as-safe-and-tolerable-dose-in-current-ocu410st-clinical-trial
Ocugen Discloses Data And Safety Monitorin...
06/21/2024 11:05:41

Six patients with Stargardt disease have been dosed in the Phase 1/2 clinical trial to date in the low dose cohort and medium d...

ocugen-begins-phase-3-trial-for-gene-therapy-to-treat-retinitis-pigmentosa
Ocugen Begins Phase 3 Trial for Gene Thera...
06/20/2024 10:32:16

Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ:OCGN), a biotechnology company focused on discovering, develop...

vanda-pharmaceuticals-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Vanda Pharmaceuticals And Other Big Stocks...
06/20/2024 09:29:09

ocgn---analyzing-ocugens-short-interest
(OCGN) - Analyzing Ocugen's Short Interest
05/31/2024 15:30:27

ocugen-announces-data-and-safety-monitoring-board-has-recommended-to-proceed-with-dosing-subsequent-ga-subjects-with-low-dose-of-ocu410-in-dose-expansion-phase-and-concurrently-initiate-phase-2-dosing
Ocugen Announces Data And Safety Monitorin...
05/31/2024 12:39:26

dxc-technology-issues-weak-outlook-joins-take-two-interactive-and-other-big-stocks-moving-lower-in-fridays-pre-market-session
DXC Technology Issues Weak Outlook, Joins ...
05/17/2024 09:34:01

nayax-posts-weak-q1-results-joins-gamestop-iris-energy-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Nayax Posts Weak Q1 Results, Joins GameSto...
05/16/2024 09:40:17

chardan-capital-maintains-buy-on-ocugen-maintains-5-price-target
Chardan Capital Maintains Buy on Ocugen, M...
05/15/2024 14:57:56

Chardan Capital analyst Daniil Gataulin maintains Ocugen (NASDAQ:OCGN) with a Buy and maintains $5 price target.

4-analysts-assess-ocugen-what-you-need-to-know
4 Analysts Assess Ocugen: What You Need To...
05/15/2024 12:01:09

hc-wainwright--co-reiterates-buy-on-ocugen-maintains-7-price-target
HC Wainwright & Co. Reiterates Buy on Ocug...
05/15/2024 10:45:47

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Ocugen (NASDAQ:OCGN) with a Buy and maintains $7 price tar...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION